🇺🇸 FDA
Patent

US 8598322

Anti CEACAM1 antibodies and methods of using same

granted A61KA61K2039/505A61K35/17

Quick answer

US patent 8598322 (Anti CEACAM1 antibodies and methods of using same) held by TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
Grant date
Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/505, A61K35/17, A61K39/39558, A61K45/06